The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
116 reports and counting
Star Therapeutics raises $125M Series D
Star Therapeutics raises $125M in Series D. Developing antibody therapies for autoimmune and inflammatory diseases...
Star Therapeutics raises $125M Series B at $600M valuation
Star Therapeutics raises $125M in Series B at $600M valuation. Antibody therapies for cancer...
Star Therapeutics raises $125M Series C at $650M valuation
Star Therapeutics raises $125M in Series C at $650M valuation. Cell therapy platform for cancer treatment...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Expedition Therapeutics raises $165M Series B at $850M valuation
Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...
Candid Therapeutics raises $370M Series A at $1.2B valuation
Candid Therapeutics raises $370M in Series A at $1.2B valuation. Developing novel therapeutics for autoimmune diseases...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.